Literature DB >> 6126363

Effects of narcotic analgesics, especially pethidine and norpethidine, on renal pelvic smooth muscle in patients with hydronephrosis.

A C Kinn, L O Boréus, A Nergårdh.   

Abstract

Relaxation of the renal pelvic smooth muscle is usually attempted as a symptomatic treatment in painful colic of the upper urinary tract. The spasmolytic potency of morphine, pethidine, pentazocine, fentanyl, naloxone and papaverine was evaluated using noradrenaline-contracted pelvic strips from hydronephrotic patients. The order of spasmolytic potency was found to be fentanyl greater than pethidine = papaverine greater than pentazocine = naloxone. Morphine produced a dual effect, starting with contraction followed by relaxation. Norpethidine, which is the only metabolite of pethidine occurring in human plasma, had the same relaxing potency as its parent compound, pethidine. Thus, an active metabolite may play a role in the outcome of spasmolytic drug treatment.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6126363     DOI: 10.1007/bf00542543

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  18 in total

1.  The effect of N-demethylation on certain pharmacologic actions of morphine, codeine, and meperidine in the mouse.

Authors:  J W MILLER; H H ANDERSON
Journal:  J Pharmacol Exp Ther       Date:  1954-10       Impact factor: 4.030

2.  Autonomic receptor functions in the normal and dilated renal pelvis: an in vitro study in man and rabbit.

Authors:  A C Kinn; A Nergårdh
Journal:  Urol Res       Date:  1979-12

3.  The role of adrenergic blockade in the treatment of ureteral colic.

Authors:  G J Kubacz; B N Catchpole
Journal:  J Urol       Date:  1972-06       Impact factor: 7.450

4.  The effect of catecholamines on ureteral peristalsis in different species (dog, guinea-pigs and rat).

Authors:  J Hannappel; K Golenhofen
Journal:  Pflugers Arch       Date:  1974       Impact factor: 3.657

5.  Use of human fetal ileum for evaluation of smooth muscle effects of narcotic analgesics.

Authors:  L O Boreus
Journal:  Eur J Pharmacol       Date:  1971-06       Impact factor: 4.432

6.  Pharmacological studies of the rabbit and human renal pelvis.

Authors:  M Del Tacca; S Lecchini; B Stacchini; M Tonini; G M Frigo; L Mazzanti; A Crema
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

7.  Pharmacokinetics and analgesic effect of pethidine (meperidine) and its metabolites in the rat.

Authors:  B E Dahlström; L K Paalzow; C Lindberg; C Bogentoft
Journal:  Drug Metab Dispos       Date:  1979 Mar-Apr       Impact factor: 3.922

8.  Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure of cancer.

Authors:  H H Szeto; C E Inturrisi; R Houde; S Saal; J Cheigh; M M Reidenberg
Journal:  Ann Intern Med       Date:  1977-06       Impact factor: 25.391

9.  Simultaneous determination of therapeutic plasma concentrations of pethidine and norpethidine in man by electron capture gas chromatography.

Authors:  P Hartvig; K E Karlsson; C Lindbert; L O Boréus
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

10.  Neonatal depression after obstetrical analgesia with pethidine. The role of the injection-delivery time interval and of the plasma concentrations of pethidine and norpethidine.

Authors:  P Belfrage; L O Boréus; P Hartvig; L Irestedt; N Raabe
Journal:  Acta Obstet Gynecol Scand       Date:  1981       Impact factor: 3.636

View more
  2 in total

1.  Comparative disposition of pethidine and norpethidine in old and young patients.

Authors:  L Holmberg; I Odar-Cederlöf; L O Boréus; L Heyner; M Ehrnebo
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

2.  Comparison of renal excretion of pethidine (meperidine) and its metabolites in old and young patients.

Authors:  I Odar-Cederlöf; L O Boréus; U Bondesson; L Holmberg; L Heyner
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.